RCEL AVITA Medical, Inc.

NASDAQ
$11.84

AVITA Medical, Inc. (RCEL) is expected to report earnings on November 9, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +97.0% since its last earnings release on August 6, 2026.

AVITA Medical Reported Earnings, Raises Guidance
Thursday, August 6, 2026 · 4:02 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $9.05

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About AVITA Medical, Inc.

AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.